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The  capacity  of  skeletal  and  cardiac  muscle  to
increase  in  size  in  response  to  increased  physio-
logical  demand  is  well  known.  However,  little  is
known  of either  the  biochemical  mechanisms  in-
volved  in  this  compensatory  hypertrophy  or  the
cellular  and  physiological  changes  resulting  from
this  growth  process.  Studies  of  protein  synthesis
during work-induced  hypertrophy  are relevant  to
such questions,  since over 80%  of the dry weight of
muscles  is protein (1).  The present  in vivo experi-
ments  compare  the  incorporation  of amino  acids
into  proteins  by  hypertrophying  and  control
muscles,  and  they  attempt  to  define  the  types  of
proteins  made  during compensatory  growth.
In order  to study  work-induced  hypertrophy  as
an  isolated  process,  we  carried  out  these  experi-
ments with hypophysectomized  animals.  Although
removal  of  the  pituitary  leads  to  cessation  of
normal  developmental  growth,  compensatory
hypertrophy  of muscle  occurs  normally  in  such
animals  (2).  Rapid  compensatory  growth  of the
soleus and plantaris muscles of one hind limb of the
rat can  be induced  by severing  the connections  of
the  gastrocnemius  to  the  Achilles  tendon  on that
side  (2,  3).  Loss  of this  muscle  imposes  a greater
work load on the remaining  extensors of the  ankle,
and within 5 days the  soleus of that limb  increases
in mass by  40%'7  and the plantaris  by  about 20%.
In the present experiments,  rats received  repeated
injections  of  leucine-
4C  after  tenotomy  of  the
gastrocnemius,  and  the  extent  of  labeling  of
proteins  in  the  hypertrophied  and  contralateral
muscles  was  measured  at  the  termination  of the
compensatory  growth.
METHODS
Male  rats weighing between  110  and  125 g  were ob-
tained  from  the  Charles  River  Laboratories  (Wil-
mington,  Mass.)  and  were  studied  5-7  wk  after
hypophysectomy.  Animals  that  gained  weight  or
showed  testicular  development  during  this  period
were  discarded.  Tenotomy  of the gastrocnemius  and
contralateral  sham operations  were performed  as  de-
scribed  previously  (2,  3).  3  uc  of uniformly  labeled
leucine-'4C  (1.89  mc/mg)  were  injected  subcutane-
ously  in 0.3  ml of physiological saline  on 5 successive
days.  The  first injection  was given  12  hr after  opera-
tion,  and the rats were sacrificed  24 hr after  the final
injection, when compensatory growth had reached  its
maximal extent  (2,  3).
The  soleus  and  plantaris  muscles  were  excised,
weighed  on  a  Roller Smith  (Bethlehem,  Pa.)  torsion
balance,  and  minced  with  a scissors.  To  insure  uni-
form  recoe ry  of  proteins  from  muscles  of  different
sizes,  we  took  samples  weighing  about  50  mg from
each  muscle.  Measurements  of radioactivity in counts
per  minute  per  milligram  were  then  multiplied  by
the  weights  of the  entire  soleus  or plantaris  for total
counts  per  muscle.  In  control  experiments,  replicate
samples  of the  plantaris  were  found  to  be  equally
labeled.
The  minced  tissues were  added to  2 ml  of a cold,
low  ionic  strength  buffer  (0.01  phosphate,  pH  7.4)
and  were  homogenized  with  a  Kontes  Duall  tissue
grinder. The  homogenates  were transferred  to centri-
fuge  tubes,  and  the  grinding  apparatus  was  rinsed
with  an  additional  milliliter  of  buffer.  The  soluble
(sarcoplasmic)  proteins  were  separated  from the  in-
soluble  (myofibrillar)  fraction  by  centrifugation  at
1,000 g  for  20  min. The  proteins  in the  supernatant
were  precipitated  by  addition  of 3  ml  of  cold  20%
trichloroacetic  acid,  and  the  myofibrillar  fraction
was  resuspended  in  3  ml  of  the  buffer.  The  tubes
were  centrifuged,  and  the  supernatants  were  dis-
carded.  The  precipitates  were  washed  twice  with
cold  5%  trichloroacetic  acid  and  once  with  a  1:1
ethanol-ether  solution.  They  were  then  dissolved  in
Nuclear-Chicago  Solubilizer  (Nuclear-Chicago  Cor-
poration,  Des  Plaines,  Ill.)  at  60
° with  occasional
shaking.  The samples were  transferred quantitatively
to vials  for  liquid  scintillation counting  in a Packard
Tricarb  Counter  (Packard  Instrument  Co., Downers
Grove,  Ill.).  The  scintillation  fluid  was composed  of
4  g  of  2,5-bis  [2-(5-tert-butylbenzoxazolyl)  ]  thio-
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liter  of toluene.
Incorporation  of  leucine-
4C  into  various  sarco-
plasmic  fractions  was  determined  after  differential
centrifugation.  In  each  experiment  the  soluble  pro-
teins from three control and three hypertrophied  mus-
cles  were  pooled.  Mitochondria  and  calcium-bind-
ing grana  were  isolated  by  centrifugation  for  I hr at
8,000  and  30,000  g,  respectively  (14).  The  superna-
tant was centrifuged for  2  hr at 100,000 g in a Model
L  Spinco Ultracentrifuge  for  sedimentation  of micro-
somal components.  All  the  pellets  were  resuspended
in 3 ml of the buffer,  and  5  mg of egg albumin  were
added  to each  as  a  carrier.  3  mnl  of 20%  trichloro-
acetic  acid  were  then  added  to  each sample  and  to
the  supernatant.  The precipitates  were  washed  and
prepared  for counting as described  above.
For  characterization  of the radioactive  proteins  in
the  insoluble  fraction,  myofibrillar  and  collagenous
materials were  separated  according  to the  method  of
Hellander  (7),  and  the  counts  in  each  component
were  assayed  in  the  usual  manner.  The  amount  of
leucine-4C in actomyosin  was estimated  after extrac-
tion by an adaptation of the procedure  of Seidel et  al.
(16).  Pooled homogenates  of three  control  and  three
hypertrophied  muscles  were  divided  into two  equal
portions, and each was centrifuged.  The counts in the
insoluble  fraction  in  one  tube were  measured  as  al-
ready described;  in the other,  the precipitate  was ex-
tracted for  2  hr with  12 ml of 0.6  M KCI, 0.1  M phos-
phate  buffer  (pH  7.0)  with  constant  shaking.  This
suspension was then centrifuged,  and the supernatant
was  dialyzed  overnight  against  2  liters  of  the  low
ionic strength  buffer.  The  precipitates  formed  in the
dialysis  sac were  transfered  quantitatively  to  centri-
fuge tubes.  Following centrifugation,  the  precipitates
were  washed,  dissolved,  and  counted  as  above.
RESULTS
6  days  after  unilateral  tenotomy  of  the  gastroc-
nemius,  the  soleus  of the  operated  limb  had  in-
creased  in weight  by  36  - 4%  and  the plantaris
by  15  2%  (Fig.  1).  In all  animals  studied, the
growing  muscles  incorporated  more  leucine-'
4C
into protein  than  did the  controls.  No  differences
were  found  between  contralateral  muscles  of
animals which  received  bilateral  sham operations.
These  results  are  summarized  in  Fig.  1,  in which
the  relative  increase  in  leucine  incorporation  by
the hypertrophying  muscle  (expressed  as per  cent
of its  contralateral  control)  is  plotted  against  the
relative  gain  in  muscle  weight.  Values  for  total
incorporation  are the sums of the counts measured
separately  in the soluble and myofibrillar fractions.
Data for both the soleus and plantaris fall  upon the
same  straight  line,  even  though  the  soleus  con-
sistently  grew  twice  as much as the plantaris,  and
even  though  the control  soleus  incorporated more
amino acids into protein  (per milligrams of tissue)
than  did  the  control  plantaris  (4).  In  both  in-
stances,  the increase  in muscle  weight was directly
proportional to the increase in amino acid incorpo-
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FIGURE  1  Relationship  of  total  in-
corporation  of  leucine-'
4C  to  gain  in
weight  by  hypertrophied  muscle.  Net
growth  and  amino  acid  incorporation
are both expressed  as per cent  increase
above that found  in muscles  of  contra-
lateral,  sham-operated  limb.  All  meas-
urements were  made  6  days  after  ten-
otomy of the  gastrocnernius  in  animals
injected  dialy with  leucineJ
4C.  Control
animals  received  no  operations  or  re-
ceived  sham  operations  on both  limbs.
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%  INCREASE  IN  MUSCLE  WET  WEIGHTresults  based  on measurements  of wet tissue  weight
are  also valid  for dry weight,  since the percentage
of water  in  the  muscles  does  not  change  during
hypertrophy  (2).
Although  greater  incorporation  of  leucine-'4C
occurred  into  both  soluble  and  myofibrillar
proteins  (Table  I),  the  ratio  of  myofibrillar  to
soluble  counts  did  not change  with hypertrophy.
In other words,  the relative increase  in incorpora-
tion  during  hypertrophy  was  similar  in  the  two
fractions.  The  appearance  of 
4C  in  soluble  and
myofibrillar proteins in  the hypertrophying  soleus
was also  measured  on  the  first,  second,  and  third
days  after tenotomy  of the gastrocnemius.  Again,
incorporation  of  leucine-1
4C  increased  propor-
tionately in  both fractions  on each  day of growth.
These  findings  suggest  that  the  growing  muscle
synthesized  fibrillar  and  soluble  proteins  in  ap-
proximately  the  same  proportions  as  in  the non-
growing  muscle.
The  assumption  that  all  radioactive  material
insoluble  at  low  ionic  strength  is  in  myofibrillar
proteins was tested  in six animals  by separation  of
collagenous  and myofibrillar  proteins (7).  In each
case,  92 % or more  of the radioactivity  of the in-
soluble  fraction  was  extracted  as  myofibrillar.
Furthermore,  at least  71 % of the labeled  proteins
of the insoluble  fraction  had  solubility  properties
similar  to  those  of  actomyosin  (Table  II).  Since
the  percentage  of radioactivity  extracted  as  acto-
myosin was  the same in hypertrophied  and control
muscles,  actomyosin  must  have been  produced  in
increased  amounts during hypertrophy.
For determination  of whether  any sarcoplasmic
component  was produced  disproportionately  dur-
ing compensatory  growth,  the  amount of leucine-
1 4C in various centrifugal  fractions  was  examined
(14).  Table III compares the distribution  of sarco-
plasmic  radioactivity  found  in  mitochondria,
calcium-binding  grana,  microsomes,  and  soluble
proteins of hypertrophied and control muscles. The
relative  amounts  of label  in  these  fractions  were
quite  uniform  in  the  different  experiments  No
significant  differences  were  seen  in  the  distribu-
tions of label  in hypertrophied  and control  soleus
muscles, even though the total incorporation  in the
former  was  much  greater.  Similar  findings  were
made on  the plantaris, in  which the distribution  of
TABLE  I
Relative Incorporation of Leucine-14C into Soluble and Fibrillar Proteins during Hypertrophy of Soleus
Total soluble cpm  Total myofibrillar  Average ratio of
myofibrillar  to per muscle  cpm per muscle  myofibllar to soluble cpm*
Hypertrophied  1092  67  1865  165  1.72  4-  0.06
Control  632  4  32  1015  4  68  1.67  0.05
Average  ratio of cpm  in  contralateral  muscles*  1.74  4  0.08  1.82  4  0.08
All measurements were made 6 days after tenotomy of the gastrocnemius.
Values  are the average  of nine  animals.
* The means  of individual  ratios found  in  the  different animals.
These results were obtained on muscles in which the average gain in weight was 33 4  3%.  Similar  results
have also been  obtained more recently when hypertrophy  equalled 46 i  3%.
TABLE  II
Leucine-'
4C Incorporation into Actomyosin  during Hypertrophy
cpm  extractable  Average of total
as actomyosin  extractable'
Control soleus  1128  4  129  802  i  88  72  2
Hypertrophied  soleus  1711  173  1228  - 147  71  4  3
Each value represents  the average  of five determinations,  each  of which was performed  on the combined
myofibrillar  fractions  of three muscles.  All  values are given  IS.E.  of means.  The hypertrophied muscles
are  the same  ones studied in  Table  I.
* The mean  of individual  ratios found  in  different experiments.
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Distribution of  Leucine-14C  into  Different  Centrifugal
Fractions
Total  sarcoplasmic  cpm
I  ypertrophied
Fraction  Control soleus  soleus
%  %
Mitochondria  (to  7.8  i  0.4  7.2  2
8,000  g)
Grana (to 30,000 g)  3.9  ±  0.3  4.5  i  0.3
Microsomes  (to  4.9  i  0.4  5.7  i  0.4
100,000  g)
Soluble  83  i  1  83  0.7
Total sarcoplasmic  3297  i  91  1931  i  66
cpm
Each value represents  the average  of four different
experiments,  each of which involved  the combined
soluble  fractions  of  three  soleus  muscles.  The
average per  cent  of total  soluble  radioactivity  ±
SE  is  given.  Hypertrophy  averaged  34  4-  3  in
this  experiment.
the  label  in  the  various  fractions  did  not  differ
from that in the  soleus.
DISCUSSION
Compensatory  hypertrophy  of  skeletal  muscle  is
accompanied  by  increased  incorporation  of
labeled amino acids into proteins. Similar  observa-
tions  have  been  reported  for  cardiac  muscle  (6,
11,  13).  Hypertrophy  also  increases  such  corre-
lates  of  protein  synthetic  activity  as  the  RNA
content  of the  muscles  (Torkelson  and  Goldberg.
Data  in  preparation.)  and  the  capacity  of  the
muscle  to concentrate  amino  acids from the blood
(5).
By  itself,  however,  the  finding  of  greater  in-
corporation  of amino  acids  into protein  does  not
necessarily  indicate  greater  protein  synthesis.
Changes in  the  sizes,  rates of labeling,  or  specific
activities  of  intracellular  amino  acid  pools  can
lead  to  greater  incorporation  of  a  radioactive
pulse  without  any  change  in  the  rate  of protein
synthesis.  Such  complications  appear  especially
important because the rate  of entry of amino  acids
into muscle  is influenced  by  the  level  of muscular
work  (5).  These  potential  complications  were
minimized  in  the present chronic  studies,  in which
total  incorporation  was  measured  after  repeated
subcutaneous injections of labeled leucine through-
out the period  of growth.  Under these  conditions,
the  increase  in  incorporation  of  labeled  amino
acids  was  directly  related  to  the  gain  in  muscle
weight.
Although  qualitative  evidence  for  an  associa-
tion  between  growth  and  increased  protein  syn-
thesis  has  been  obtained  in  a  wide  variety  of
tissues,  quantitative  studies  of  this  relationship
have  been reported only for exponentially growing
bacteria  (9).  In such  microorganisms,  growth  was
also  found  to  be  linearly  related  to  amino  acid
incorporation.  Quantitative  data,  such  as  those
presented  in  Fig.  1,  are  difficult  to  obtain  in
higher organisms  because  of technical  problems in
quantifying  organ  growth  and the  associated  bio-
chemical  changes  without  using  prohibitively
large  numbers  of  animals.  In the  present  experi-
ments  this  difficulty  was  circumvented  by  com-
paring  data  on  paired  growing  and  nongrowing
muscles  in  the  same  hypophysectomized  animal.
Interpretation  of  the  linear  relationship  de-
scribed in Fig.  I is complicated  by the phenomenon
of protein turnover. In the absence of protein deg-
radation,  e.g.  in  exponentially  growing  bacteria
(9,  10), the amount of growth must be proportional
to  the  amount  of  new  protein  synthesized.  This
simple  relationship  cannot  hold  for  muscle  or
other  mammalian  cells  in  which  the  half-lives  of
proteins  are much  shorter than  the  half-life  of the
cell.  Even  in  the  absence  of growth,  protein syn-
thesis must occur  in such cells  to replace degraded
proteins  and  to maintain  cell  size.  Fig.  1 demon-
strates  that  for  muscle  the  amount  of  growth  is
proportional  only  to  the  amount  of protein  syn-
thesized in excess  of that required  to  balance  deg-
radative  processes,  i.e.  in  excess of the incorpora-
tion in the nongrowing control.
Since protein synthesis and protein degradation
are  equally  balanced  in  nongrowing  muscle,  one
can estimate,  from measurements  of average  turn-
over  rates  of muscle  protein,  the  amount  of  pro-
tein synthesized  by the controls  during  the period
studied.  The  smallest  reported  value  for  average
half-life  of  skeletal  muscle  proteins  is  23.4  4
days  (6).  At  this  rate,  17  ±  2%  of the  original
protein mass of the muscle would be catabolized  in
6 days. The leucine-
4 C incorporated into the non-
growing  controls,  therefore,  corresponds  to  the
replacement  of this  amount  of protein.  Doubling
the incorporation  of 14C during hypertrophy would
thus be expected  to cause at most only a  17  r  gain
in  muscle  weight,  rather  than  the  40%  gain
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increase  in  incorporation,  i.e.  the  slope  of Fig.  1,
appears  too  small  by a  factor of 2 or 3 to account
for  the  observed  growth.
A number  of possible  effects  could explain  this
result.  (a)  If the  amino  acid  pool  in  the  hyper-
trophying  muscle  had  a  lower  specific  activity
than  that  in  the  control,  the  incorporation  data
would  underestimate  the  protein  synthesis  in  the
growing  muscle.  Although  information  on amino
acid  pools  in hypertrophying  muscle  is  presently
lacking,  this  possibility  appears  unlikely  because
hypertrophying  muscles  concentrate  AIB-'4C from
the  blood  more  actively  than  controls  (5).  ()
Alternatively  during hypertrophy,  there  could  be
increased  synthesis  of  some  muscle  components,
e.g.  collagen,  which  contain  little  leucine  and
therefore  would  be  poorly  labeled.  (c) The  value
used  for  the  average  half-life  of  muscle  protein
may  be  too large;  thus  a given  amount of leucine
incorporation  could  actually  correspond  to  more
protein  synthesis  than  was  estimated  above.  (c)
It  is  also possible  that decreased  protein degrada-
tion is an  important  mechanism  of compensatory
growth.  In  fact,  recent  evidence  indicates  that
average  half-lives  of muscle  proteins are prolonged
during  hypeltrophy  (Goldberg.  Data  in  prepara-
tion.).  Further  experiments  are  in  progress  to
decide  between  these possibilities.
During  hypertrophy,  soluble  and  myofibrillar
proteins  appeared  to  be  synthesized  in  approxi-
mately  the  same  relative  proportions  as  in  non-
growing  control  (Table  II).  The  data  on  the
distribution  of  newly  synthesized  proteins  into
various  sarcoplasmic  fractions  (mitochondria,  Ca-
binding grana,  microsomes,  and  soluble  proteins)
argue  against  the  disproportionate  synthesis  of
any  of  these  cellular  components  in  response  to
increased  work.  Proportionate  increases  in  the
rates  of  synthesis  of  these  various  components,
however,  do  not necessarily  lead  to proportionate
increases  in  their  concentrations  in  the  muscle.
Since  the  amount  of  any  cellular  component
depends  on  both  its  synthetic  and  degradative
rates  (15),  changes  in  protein  half-lives  during
hypertrophy  could  alter  the  composition  of  the
cell even though  the  rates  of synthesis  of these dif-
ferent  components  increase  in  parallel  (Tables
I  and  III).  Thus,  the  present  findings  are  not
necessarily  in  disagreement  with  the  earlier  ob-
servation  that  the  leg muscles of exercised  rabbits
have  a  higher  content  of  myofibrillar  proteins
than  those  of restrained  animals  (8),  or  with  the
various  morphological  studies  that  have  empha-
sized  the  increase  in  myofibrils  during  hyper-
trophy  (1,  12).  It  is  apparent  that  a  full  under-
standing  of  the  cellular  processes  involved  in
compensatory  growth  will  require  information  on
rates  of  protein  degradation  as  well  as  protein
synthesis.
SUMMARY
The incorporation  of leucine- 1 4C  into proteins was
studied during compensatory  growth  of the  soleus
and  plantaris  muscles.  Growth  of  these  muscles
of  one  limb  was  induced  by  tenotomy  of  the
synergistic  gastrocnemius muscle. At the end of the
growth  period,  these  muscles  showed  greater
incorporation of leucine-4C  into proteins  than did
contralateral  controls,  and  the  final  gain  in
muscle  weight  was  directly  proportional  to  the
increase in  amino  acid incorporation.  Soluble and
myofibrillar  proteins  appeared  to  be  synthesized
in the same proportions as in nongrowing  muscles.
The  relative  incorporation  of  leucine-
4 C  into
various  sarcoplasmic  components  (mitochondria,
Ca-binding  grana,  microsomes,  and  soluble
proteins)  was  also  similar in  hypertrophying  and
control  muscles.  The  increase  in  amino  acid
incorporation,  however,  appears  too  small  to
account  entirely  for  the  gain  in muscle  weight.
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